PATENT CLAIM ANALYSIS

Application Number: 16045358
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["544", "281000"]

Abstract:
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

Claim (Index 52):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein:\n R 1  is methyl; R 2  is ethoxy, phenyl, or 3-fluorophenyl; R 3a  is H, methyl, isopropyl, isobutyl, \u2014CH 2 C\u2261CCH 3 , \u2014CH 2 CH 2 OH, \u2014CH 2 CH 2 OCH 3 , \u2014CH 2 CN, \u2014CH 2 CH 2 NH 2 , \u2014CH 2 C(O)NH 2 , benzyl, cyclobutyl, \u2014CH 2 -(1-methyl-1H-pyrazol-3-yl), or \u2014CH 2 CH 2 -(morpholin-4-yl); R 4a  is H, methyl, ethyl, isopropyl, isobutyl, \u2014CH 2 C\u2261CCH 3 , \u2014CH 2 CH 2 OH, \u2014CH 2 CH 2 OCH 3 , \u2014CH 2 CN, \u2014CH 2 CH 2 NH 2 , cyclobutyl, benzyl, \u2014CH 2 C(O)NH 2 , \u2014CH 2 -(1-methyl-1H-pyrazol-3-yl), or \u2014CH 2 C(O)-(morpholin-4-yl); R 5  is H, bromo, or methyl; and R 6  is chloro, CN, or methyl.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.27778
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15343375', '15631417', '13085643', '13329532', '14872881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8260467529410883
- 35 USC 102 Novelty (BERT): 0.6018298276778181
- Combined Prediction Score: 0.8036250604147612
- Mean Citation Score: 421.74511
- Max Citation Score: 495.84445
- Similarity Product: 397.23163631776566

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test